Page last updated: 2024-09-04

tx 3301 and Kidney Diseases

tx 3301 has been researched along with Kidney Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Allon, M; Beck, GJ; Braden, GL; Cotton, JR; Davidson, IJ; Delmez, JA; Dember, LM; Dixon, BS; Feldman, HI; Greenberg, A; Greene, T; Himmelfarb, J; Hu, B; Ikizler, TA; Kusek, JW; Lawson, JH; Radeva, MK; Vazquez, MA	1

Trials

1 trial(s) available for tx 3301 and Kidney Diseases

Article	Year
Use of aspirin associates with longer primary patency of hemodialysis grafts. Journal of the American Society of Nephrology : JASN, 2011, Volume: 22, Issue:4 Topics: Adult; Aged; Arteriovenous Shunt, Surgical; Aspirin; Aspirin, Dipyridamole Drug Combination; Chronic Disease; Dipyridamole; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Kidney Diseases; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Renal Dialysis; Thrombosis; Treatment Outcome; Vascular Patency	2011

Article

Year

Use of aspirin associates with longer primary patency of hemodialysis grafts.

Journal of the American Society of Nephrology : JASN, 2011, Volume: 22, Issue:4

Topics: Adult; Aged; Arteriovenous Shunt, Surgical; Aspirin; Aspirin, Dipyridamole Drug Combination; Chronic Disease; Dipyridamole; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Kidney Diseases; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Renal Dialysis; Thrombosis; Treatment Outcome; Vascular Patency

2011